Pacgen Life Science (PBS) Hits New 1-Year Low at $0.04

Shares of Pacgen Life Science Corp (CVE:PBS) reached a new 52-week low during mid-day trading on Thursday . The company traded as low as C$0.04 and last traded at C$0.04, with a volume of 30000 shares changing hands. The stock had previously closed at C$0.04.

ILLEGAL ACTIVITY NOTICE: This piece was originally published by Stock Observer and is owned by of Stock Observer. If you are accessing this piece on another site, it was stolen and reposted in violation of United States and international trademark & copyright legislation. The correct version of this piece can be accessed at https://www.thestockobserver.com/2018/12/08/pacgen-life-science-pbs-hits-new-1-year-low-at-0-04.html.

Pacgen Life Science Company Profile (CVE:PBS)

Pacgen Life Science Corporation, a life sciences company, focuses on building a commercial platform to market and distribute consumer health products in North America. It markets its oral and skin care products under the P113+, DermaMed, DermaSoleil, and Deserving Health brand names. The company was formerly known as Pacgen Biopharmaceuticals Corporation and changed its name to Pacgen Life Science Corporation in May 2012.

Featured Story: No Load Funds

Receive News & Ratings for Pacgen Life Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pacgen Life Science and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply